Proveri Prostate Cancer Assay (PPCA™)
Definitive diagnosis for ambiguous cases reducing the need for additional biopsies.
Improving Prostate Cancer Diagnosis & Prognosis One Patient at a Time.
Our initial product, Proveri Prostate Cancer Assay (PPCA™) helps clinicians detect and diagnose prostate cancer earlier, faster and more accurately.
Site Navigation
Patient Diagnosis Flow Chart
PPCA™ Facts
- Diagnostic biomarkers combined with proprietary imaging and analysis technology.
- Cancer diagnosis in the absence of tumor in biopsy samples
- Major patent granted for licensed technology
- SBIR NCI contract Phase I successfully completed